Candel Therapeutics Inc (CADL) Live Share Price, Invest From India

Candel Therapeutics Inc Stock Performance

as on May 2, 2026 at 6:59 am IST

Day's Low
Day's High
$6.11
Day's Price Range
$6.52
$6.47
5.56%
Downside
0.77%
Upside
52 Week's Low
52 Week's High
$4.34
52-Week Price Range
$7.66
$6.47
32.95%
Downside
18.32%
Upside

Candel Therapeutics Inc share price movements today

Previous Close: $6.18
Open: $6.15
Volume: 2.3M
Day's Low - High: $6.11 - $6.52
52 Week Low - High: $4.34 - $7.66

Candel Therapeutics Inc Historical Returns

1 Month Return: + 29.4 %
3 Month Return: + 10.22 %
1 Year Return: + 22.54 %
3 Year Return: + 312.1 %
5 Year Return: 0 %

Candel Therapeutics Inc Stock Fundamentals & Key Indicators

Check Candel Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$452.8M

EPS (TTM)

-0.77

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-47.3M

Revenue (TTM)

31.0K

Profit Margin

0.00%

Return On Equity TTM

-64.58%

Candel Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Candel Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Candel Therapeutics Inc	BUY	$452.8M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	110.54%	77.57	12.55%
Vertex Pharmaceuticals Inc	BUY	$108.7B	94.28%	27.93	32.94%
BeiGene, Ltd.	NA	$32.7B	NA	118.49	5.37%
Regeneron Pharmaceuticals Inc	BUY	$74.1B	45.73%	17.27	29.65%

Stock Returns calculator for Candel Therapeutics Inc Stock including INR - Dollar returns

The Candel Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Candel Therapeutics Inc investment value today

Current value as on today

₹1,37,488

Returns

₹37,488

(+37.49%)

Returns from Candel Therapeutics Inc Stock

₹22,538 (+22.54%)

Dollar Impact

₹14,950 (+14.95%)

Analyst Recommendation on Candel Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Candel Therapeutics Inc. Average target price of $18.88

Candel Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Candel Therapeutics Inc.

What analysts predicted

65.73%UPSIDE

Target Price

$18.88

Current Price

$6.47

Analyzed by

7 Analysts

Target

$18.88

Candel Therapeutics Inc target price $18.88, a slight upside of 65.73% compared to current price of $6.47. According to 7 analysts rating.

Candel Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Candel Therapeutics Inc Stock has increased by 282% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 2, 2026 to May 2, 2026

Change:282% versus previous 30 day period

Candel Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	1	1	-	-	1	-	-	-	-
Gross Profit	-5	1	0	-4	-5	0	0	0	0	0
Operating Income	-8	-10	-7	-8	-8	-8	-8	-11	-13	-15
EBITDA	-8	-10	-7	-8	-8	-13	7	-4	-10	-40
Interest Expense	0	0	0	0	0	0	0	0	0	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-11	-8	-22	-10	-14	7	-4	-11	-29
Income Tax Expense	0	0	0	0	-	-	-	-	-	-
Net Income	-8	-11	-8	-22	-10	-14	7	-4	-11	-29
Net Profit Margin	0.00%	-624.72%	-462.89%	0.00%	0.00%	-1407.30%	0.00%	0.00%	0.00%	0.00%

Candel Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	0	0	0	-	-
Gross Profit	-6	0	0	0	-23	0	0
Operating Income	-9	-13	-25	-34	-38	-33	-48
EBITDA	-8	-13	-35	-16	-37	-52	-47
Interest Expense	1	0	0	1	0	2	2
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-8	-17	-36	-18	-37	-55	-38
Income Tax Expense	0	4	10	-15	-	-	-
Net Income	-8	-17	-36	-18	-37	-55	-38
Net Profit Margin	-6592.00%	-14144.00%	-28899.20%	-15035.20%	-122383.87%	0.00%	0.00%

Candel Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-11	-8	-22	-10	-14	7	-4	-11	-29
Operating Cash Flow	-7	-8	-6	-6	-5	-8	-8	-10	-10
Investing Cash Flow	-	0	0	-	0	0	0	0	0
Financing Cash Flow	0	-1	1	1	91	-1	17	-3	43
Change in Cash	-7	-9	-4	-4	86	-10	8	-13	32

Candel Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-17	-36	-18	-37	-55	-38
Operating Cash Flow	-9	-22	-31	-34	-27	-38
Investing Cash Flow	38	-1	-1	0	0	0
Financing Cash Flow	0	71	19	0	94	56
Change in Cash	29	47	-12	-34	67	17

Global Institutional Holdings in Candel Therapeutics Inc

Funds	Holdings
Vanguard Group Inc	3.15%
Baker Bros Advisors LP	0.65%
Portolan Capital Management, LLC	2.31%
State Street Corp	1.08%
Nuveen, LLC	0.29%

See all

Insights on Candel Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, CADL has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 month, CADL stock has moved up by 29.4%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CADL has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, 7.37M → -29.49M (in $), with an average decrease of 153.9% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.77M → 1.0M (in $), with an average decrease of 43.7% per quarter

About Candel Therapeutics Inc

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.

Organisation	Candel Therapeutics Inc
Headquarters	117 Kendrick Street, Needham, MA, United States, 02494
Industry	Biotechnology
CEO	Ms. Ileen B. Winick
E-voting on shares	Click here to vote

Key Management of Candel Therapeutics Inc

Name	Title
Ms. Susan Stewart J.D., L.L.M.	Chief Regulatory Officer
Dr. William Nichols Garrett M.D., M.S.	Chief Medical Officer
Ms. Ileen B. Winick	Chief People Officer

FAQs

What is Candel Therapeutics Inc share price today?

Candel Therapeutics Inc share price today is $6.47 as on May 2, 2026 at 1:29 am IST at the close of the market. Candel Therapeutics Inc share today touched a day high of $6.52 and a low of $6.11.

What is the 52 week high and 52 week low for Candel Therapeutics Inc share?

Candel Therapeutics Inc share touched a 52 week high of $7.66 on April 20, 2026 and a 52 week low of $4.34 on May 8, 2025. Candel Therapeutics Inc stock price today i.e. May 2, 2026 at 1:29 am IST is closed at $6.47,which is 15.48% down from its 52 week high and 49.13% up from its 52 week low.

What is Candel Therapeutics Inc's market capitalisation today?

Candel Therapeutics Inc market capitalisation is $0.00T as on May 2, 2026 at 1:29 am IST.

How to invest in Candel Therapeutics Inc Stock (CADL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Candel Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Candel Therapeutics Inc Shares that will get you 0.2318 shares as per Candel Therapeutics Inc share price of $6.47 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Candel Therapeutics Inc Stock (CADL) from India?

Indian investors can start investing in Candel Therapeutics Inc (CADL) shares with as little as ₹94.91 or $1 (as of May 2, 2026 at 6:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Candel Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 2, 2026 at 6:42 pm IST). Based on Candel Therapeutics Inc share’s latest price of $6.47 as on May 2, 2026 at 1:29 am IST, you will get 1.5456 shares of Candel Therapeutics Inc. Learn more about fractional shares .